.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The Indian government recently announced a significant Customs Duty Exemption on 40 petrochemical inputs. This measure aims to protect the pharmaceutical and medical technology sectors from rising costs. These industries currently face immense pressure due to the ongoing conflict in West Asia. Consequently, the Finance Ministry released a comprehensive list of products eligible for this temporary relief. This policy remains effective until June 30 to ensure the steady supply of essential medical goods.
Industry leaders have welcomed this proactive step to stabilize the domestic healthcare market. The Indian Pharmaceutical Alliance (IPA) noted that the conflict disrupts the timely movement of products. Specifically, raw materials like Polypropylene, ABS, and PVC resin are vital for medical consumables. Previously, input prices surged by up to 50 percent because of freight hikes and supply shortages. Therefore, the Customs Duty Exemption directly addresses these inflationary pressures. Manufacturers expect this move to lower production costs for critical items like MRI scanners and low-risk consumables.
Besides immediate tax relief, the industry seeks long-term structural changes. For instance, medical device makers have requested lower GST rates on raw materials. Currently, many APIs and reagents attract an 18 percent GST rate. Reducing this to 5 percent could further boost the global competitiveness of Indian goods. Furthermore, the IPA suggested forming an 'Empowered Committee of Secretaries' for better coordination. These steps would help maintain an uninterrupted supply of critical healthcare products during global volatility.
Q1: Why did the government announce this duty exemption?
The government introduced the measure to offset rising costs and supply chain disruptions caused by the conflict in West Asia, which impacted petrochemical feedstocks used in medicine production.
Q2: Which materials are included in the exemption list?
The exemption covers 40 petrochemical inputs, including Polypropylene, ABS, Polycarbonate, and PVC resin, which are essential for manufacturing medical consumables and devices.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The Centre has exempted 40 petrochemical inputs from customs duty until June 30 to help pharma and medtech manufacturers manage rising costs from global con...
5 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
